Keywords: europe/us, sales, offset, asian, crisis, schering, ag
Europe/US sales offset Asian crisis at Schering
Article | 09 February 1999
Schering AG, the German pharmaceuticals group, has reported groupprofits of 478 million Deutschemarks ($276.8 million) for 1998, an increase of 7% compared with the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
